Valuation Stability

Omda’s fair‑value target remains at NOK 59.0, underscoring a stable valuation anchor despite recent model tweaks. Analysts highlighted the company’s strong Q4 performance, citing an 8 % revenue beat and a $7 m EBITDA beat, while noting that valuation pressure in the Healthcare Information Technology sector and client concentration could temper upside expectations. Positive ratings are held by Canaccord, Morgan Stanley, Goldman Sachs, and Barclays, all of whom point to potential upside if Omda meets its conservative 2026 outlook. Barclays, in particular, indicates that the revenue outlook leaves room for further upside, whereas Wells Fargo’s Equal‑Weight initiation at a US$17 target flags client concentration and ownership structure as risks that could affect the company’s competitive position. Omda AS has reaffirmed its 2026 earnings guidance, maintaining an expected revenue range of NOK 500 m to NOK 525 m, and affirmed that its medium‑term plans remain intact, with the reiterated guidance serving as a key reference point for investors.